Investments and Collaborations Boost Global Point-of-care Diagnostic Market Growth

Point-of-care diagnostic market was valued at $44,240 million in 2024 and is projected to reach $85,737 million by 2035, growing at a CAGR of 6.2% from 2025 to 2035. Strategic funding from venture capitalists, healthcare institutions, and government agencies is enabling startups to commercialize and scale their technologies, driving market growth. For instance, in January 2025, Novus Diagnostics secured $4.85 million in equity financing to develop its flagship product, SepTec, a rapid point-of-care diagnostic technology platform. The funding, led by BVP Investments, Trinity Biotech, and Irrus Investments, will accelerate the development of SepTec, a tool that can diagnose and classify bloodstream infections in 15 minutes, transforming sepsis diagnosis and treatment. 

Browse the full report description of “Point-of-care Diagnostic Market Size, Share & Trends Analysis Report by Type (Glucose Monitoring Kits, Cardiometabolic Monitoring Kits, Infectious Disease Testing Kits, Pregnancy & Fertility Testing Kits, Tumor/Cancer Markers, Urinalysis Testing Kits, Cholesterol Testing Kits, Haematology Testing, and Others), by Prescription Mode (Over-The-Counter Testing, and Prescription-Based Diagnostics), by Technology (Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics, Immunoassays, and Biosensors), and by End-User (Hospitals and Clinics, Home Care, Ambulatory Care, Diagnostic Laboratories, and Pharmacies) Forecast Period (2025-2035)” at https://www.omrglobal.com/industry-reports/point-of-care-diagnostics-market

Recent Developments

• In July 2024, NOWDiagnostics secured $22.5 million in Series B funding, which enabled the commercialization of at-home diagnostic tests, the development of new diagnostic innovations, and support for strategic hiring initiatives. The company's patented technology platform, with over 75 patents, allows accurate immunological assays in one step using capillary blood, saliva, and plasma test technologies, enhancing accessibility and allowing individuals to take necessary steps for their health in the privacy of their homes.

• In September 2024, Vigilant Diagnostics secured an additional $500,000 equity investment to advance its rapid, point-of-care diagnostic technology, bringing its total funding to $2,000,000, with the company partnering with universities, design firms, and contract manufacturers.

• In December 2024, PocDoc secured £5 million ($6.3 million) in pre-series A funding to expand its digital diagnostics business. The funding round brings PocDoc's total pre-A funding to over $10.8 million. The firm raised $5.4 million from MMC Ventures, Molten VC, and Simplyhealth Ventures. KHP Ventures, an NHS-anchored venture fund, also participated. PocDoc's platform uses machine learning, data integration, and real-time alerting.

Market Coverage

• The market numbers available for 2024-2035

• Base year- 2024

• Forecast period- 2025-2035

• Segment Covered- 

o By Type

o By Prescription Mode

o By  Technology

o By End-User

• Regions Covered-

o North America

o Europe

o Asia-Pacific

o Rest of the World

• Competitive Landscape - Abbott Laboratories, Danaher Corp., F. Hoffmann-La Roche Ltd., Siemens Healthcare Pvt. Ltd., and Thermo Fisher Scientific Inc., among others.

Key questions addressed by the report.

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Point-of-care Diagnostic Market Report Segment

By Type

• Glucose Monitoring Kits
• Cardiometabolic Monitoring Kits
• Infectious Disease Testing Kits
• Pregnancy & Fertility Testing Kits
• Tumor/Cancer Markers
• Urinalysis Testing Kits
• Cholesterol Testing Kits
• Haematology Testing
• Others (Coagulation Testing Kits and Fecal Occult Testing Kits)

By Prescription Mode

• Over-The-Counter Testing
• Prescription-Based Diagnostics

By Technology

• Lateral Flow Assays
• Dipsticks
• Microfluidics
• Molecular Diagnostics
• Immunoassays
• Biosensors

By End-User

• Hospitals and Clinics
• Home Care
• Ambulatory Care
• Diagnostic Laboratories
• Pharmacies

Global Point-of-care Diagnostic Market Report Segment by Region

North America

• United States

• Canada 

Europe

• UK

• Germany

• Italy

• Spain

• France

• Russia

• Rest of Europe 

Asia-Pacific

• China

• India

• Japan

• South Korea

• Australia and New Zealand

• ASEAN Economies

• Rest of Asia-Pacific 

Rest of the World

• Latin America 

• Middle East & Africa

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/point-of-care-diagnostics-market